Allena Pharmaceuticals, Inc.
ALNADelisted Sep 14, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001624658
Allena Pharmaceuticals, Inc. was delisted on Sep 14, 2022; its insiders filed their last Form 4 on Feb 2, 2022; 25 institutions reported holding it in 13F filings for Q2 2022, worth $1.71M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Allena Pharmaceuticals, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −5 vs. Q3 2021
- Shares held
- 17.0M
- −2.88M (−14.5%) vs. Q3 2021
- Total value
- $10.1M
- −$7.86M (−43.8%) vs. Q3 2021
- New holders
- 4
- 7 more added
- Sold out
- 9
- 8 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 2 | $4.00K |
| Q2 2022 | 25 | $1.71M |
| Q1 2022 | 28 | $1.86M |
| Q4 2021 | 30 | $10.1M |
| Q3 2021 | 36 | $18.0M |
| Q2 2021 | 29 | $28.1M |
| Q1 2021 | 30 | $28.3M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Allena Pharmaceuticals, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 4,000,000 | $2.37M | 0.74% | 00.0% | Unchanged |
| Vanguard Group Inc | 3,290,755 | $1.95M | 0.00% | +1,283,724+64.0% | Added |
| TRV GP II, LLC | 2,790,964 | $1.65M | 6.84% | 00.0% | Unchanged |
| Frazier Management LLC | 1,651,357 | $978.0K | 0.08% | −1,679,016−50.4% | Reduced |
| FMR LLC | 1,245,009 | $738.0K | 0.00% | −1,051,074−45.8% | Reduced |
| Morgan Stanley | 1,045,481 | $619.0K | 0.00% | 00.0% | Unchanged |
| Worth Venture Partners, LLC | 980,200 | $581.0K | 0.29% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 330,599 | $195.0K | 0.00% | 00.0% | Unchanged |
| PFM Health Sciences, LP | 284,285 | $168.0K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 264,239 | $156.0K | 0.00% | +8,819+3.5% | Added |
| State Street Corp | 205,058 | $121.0K | 0.00% | 00.0% | Unchanged |
| Kestra Advisory Services, LLC | 161,500 | $96.0K | 0.00% | +56,500+53.8% | Added |
| Virtu Financial LLC | 133,829 | $79.0K | 0.01% | +133,829 | New |
| Bridgeway Capital Management, LLC | 124,200 | $74.0K | 0.00% | −111,800−47.4% | Reduced |
| Spire Wealth Management | 91,940 | $54.0K | 0.00% | +41,940+83.9% | Added |
| Northern Trust Corp | 89,363 | $53.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 59,999 | $35.0K | 0.00% | +22,313+59.2% | Added |
| Natixis | 50,000 | $30.0K | 0.00% | 00.0% | Unchanged |
| Level Four Advisory Services, LLC | 40,000 | $24.0K | 0.00% | +40,000 | New |
| LPL Financial LLC | 30,550 | $18.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 29,825 | $17.0K | 0.00% | −17,150−36.5% | Reduced |
| Golden Green, Inc. | 25,000 | $15.0K | 0.01% | −8,000−24.2% | Reduced |
| Advisor Group Holdings, Inc. | 23,000 | $14.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 14,869 | $9.00K | 0.00% | +530+3.7% | Added |
| Jane Street Group, LLC | 13,246 | $8.00K | 0.00% | −40,718−75.5% | Reduced |
| Victory Capital Management Inc | 11,051 | $7.00K | 0.00% | −9−0.1% | Reduced |
| The PNC Financial Services Group, Inc. | 10,000 | $6.00K | 0.00% | +10,000 | New |
| Bank of America Corp | 5,800 | $3.00K | 0.00% | −100−1.7% | Reduced |
| Wells Fargo & Company | 2,952 | $1.00K | 0.00% | +1,529+107.4% | Added |
| TAP Consulting, LLC | 30 | $0 | 0.00% | +30 | New |
| Altium Capital Management LP | 0 | $0 | 0.00% | −1,067,886−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −152,731−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −132,700−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −83,689−100.0% | Sold out |
| Quilter Plc | 0 | $0 | 0.00% | −52,204−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −46,713−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −21,443−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −5,189−100.0% | Sold out |
| Harbor Financial Services, LLC | – | – | – | – | Not filed |